Quarterly report pursuant to Section 13 or 15(d)

Fair Value Measurements (Details 1)

v3.2.0.727
Fair Value Measurements (Details 1) - USD ($)
6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Balance, beginning   $ 23
Change in fair value of Teva option   (23)
Estimated fair value of warrants assumed in merger on January 2, 2014   10,475
Estimated fair value of warrants issued in January 2014 common stock sale   $ 3,696
Estimated fair value of warrants exchanged for common shares $ 13,862,000  
Change in fair value of warrants for the year ended December 31, 2014   $ (7,721)
Balance, ending   $ 6,450
Unobservable Inputs (Level 3) [Member]    
Balance, beginning $ 8,464  
Change in fair value of Teva option    
Estimated fair value of warrants assumed in merger on January 2, 2014    
Estimated fair value of warrants issued in January 2014 common stock sale    
Estimated fair value of warrants exchanged for common shares $ (13,862)  
Change in fair value of warrants for the year ended December 31, 2014 11,528  
Balance, ending $ 6,130